Our top pick for
Blackbaud, Inc is a software-application business based in the US. Blackbaud shares (BLKB) are listed on the NASDAQ and all prices are listed in US Dollars. Blackbaud employs 3,100 staff and has a trailing 12-month revenue of around USD$913.2 million.
|52-week range||USD$38.22 - USD$80|
|50-day moving average||USD$69.0721|
|200-day moving average||USD$60.3525|
|Wall St. target price||USD$75.25|
|Dividend yield||USD$0.12 (0.17%)|
|Earnings per share (TTM)||USD$0.16|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Blackbaud stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Blackbaud's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Blackbaud's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 441x. In other words, Blackbaud shares trade at around 441x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Blackbaud's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.3438. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Blackbaud's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Blackbaud's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$121 million.
The EBITDA is a measure of a Blackbaud's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$913.2 million|
|Operating margin TTM||6.65%|
|Gross profit TTM||USD$490.4 million|
|Return on assets TTM||1.88%|
|Return on equity TTM||1.88%|
|Market capitalisation||USD$3.4 billion|
TTM: trailing 12 months
There are currently 2.0 million Blackbaud shares held short by investors – that's known as Blackbaud's "short interest". This figure is 0.5% down from 2.0 million last month.
There are a few different ways that this level of interest in shorting Blackbaud shares can be evaluated.
Blackbaud's "short interest ratio" (SIR) is the quantity of Blackbaud shares currently shorted divided by the average quantity of Blackbaud shares traded daily (recently around 392249.00793651). Blackbaud's SIR currently stands at 5.04. In other words for every 100,000 Blackbaud shares traded daily on the market, roughly 5040 shares are currently held short.
However Blackbaud's short interest can also be evaluated against the total number of Blackbaud shares, or, against the total number of tradable Blackbaud shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Blackbaud's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Blackbaud shares in existence, roughly 40 shares are currently held short) or 0.0472% of the tradable shares (for every 100,000 tradable Blackbaud shares, roughly 47 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Blackbaud.
Find out more about how you can short Blackbaud stock.
Dividend payout ratio: 75% of net profits
Recently Blackbaud has paid out, on average, around 75% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.97% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Blackbaud shareholders could enjoy a 0.97% return on their shares, in the form of dividend payments. In Blackbaud's case, that would currently equate to about $0.12 per share.
Blackbaud's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Blackbaud's most recent dividend payout was on 13 March 2020. The latest dividend was paid out to all shareholders who bought their shares by 27 February 2020 (the "ex-dividend date").
Over the last 12 months, Blackbaud's shares have ranged in value from as little as $38.22 up to $80. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Blackbaud's is 1.1569. This would suggest that Blackbaud's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Blackbaud, Inc. provides cloud software solutions to nonprofits, foundations, companies, education institutions, healthcare organizations, and other social good entities in the United States and internationally. The company offers fundraising and relationship management solutions, such as Blackbaud Raiser's Edge NXT and Blackbaud CRM, Blackbaud TeamRaiser, Blackbaud Peer-to-Peer Fundraising, and Blackbaud Guided Fundraising and Blackbaud Volunteer Network Fundraising; marketing and engagement solutions, including Blackbaud Luminate Online, Blackbaud Luminate Advocacy, Blackbaud Online Express, and Blackbaud School Website System; and financial management solutions, comprising of Blackbaud Financial Edge NXT, Blackbaud Tuition Management, and Blackbaud Financial Aid Management. It also provides grant and award management solutions, consisting of Blackbaud Grantmaking, Blackbaud Outcomes, and Blackbaud Award Management; organizational and program management, such as Blackbaud Student Information System, Blackbaud Learning Management System, Blackbaud Enrollment Management System, Blackbaud Altru, and Blackbaud Church Management; social responsibility solutions, which includes YourCause Grants Connect and YourCause CSR; Blackbaud Merchant Services and Blackbaud Purchase Cards payment services; and Blackbaud's Intelligence for Good solutions, as well as donor acquisition, prospect research, data enrichment, and benchmarking and performance management solutions and services. It sells its solutions and related services through its direct sales force. The company was founded in 1981 and is headquartered in Charleston, South Carolina.
Everything we know about the Reddit IPO, plus information on how to buy in.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.